Drug intelligence / Profile preview

Vitaswit Softgels

Development stage: Unknown
Lead developer: Switzer Life Sciences
Modality: Small Molecules
Administration: Oral

Overview

Vitaswit Softgels is a multivitamin and multimineral nutritional supplement developed and marketed by Switzer Life Science. Formulated as a soft gelatin capsule, it is designed to provide a comprehensive blend of essential micronutrients, including vitamins (such as A, B-complex, C, D3, and E) and minerals (such as Zinc and Magnesium). The product is intended for oral administration to address nutritional deficiencies, support immune function, and maintain overall metabolic health. As a branded generic formulation from a manufacturer focused on generic drug products and exports, Vitaswit Softgels serves as a therapeutic supplement for individuals with inadequate dietary intake or increased physiological demands.

Brand names: Vitaswit Softgels

Targets

RAR (Retinoic acid receptor)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on Vitaswit Softgels.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitaswit Softgels.